Delve, an AI-powered compliance startup, has secured $32 million in a Series A funding round led by Insight Partners, raising its valuation to $300 million. The company has evolved from automating HIPAA compliance to offering a comprehensive platform leveraging AI agents to automate regulatory compliance for over 500 clients.
This investment follows a $3 million seed round announced in January, boosting the company’s valuation nearly tenfold, with participation from several Fortune 500 CISOs.
Delve develops AI agents that integrate with internal company tools to automate manual compliance processes — including evidence collection, report generation, audit log updates, and system configuration monitoring — in real time. Its client base has grown from 100 in January to more than 500, including AI startups like Lovable, Bland, and Wispr Flow.
Founded by Karun Kaushik and Selin Kocalar after meeting at MIT while developing an AI healthcare product, the company was inspired by the challenge of meeting HIPAA requirements. This led to the creation of Delve, designed to make compliance faster and more cost-effective. In 2023, Delve joined Y Combinator and raised seed funding from General Catalyst, FundersClub, and Soma Capital.
COO Selin Kocalar stated:
“Our long-term vision is to automate back-office operations beyond compliance, including cybersecurity, risk management, and internal audits.”
CEO Karun Kaushik said:
“Compliance frameworks are standard, but companies are unique. Delve bridges that gap with AI.”
Praveen Akkiraju, Managing Director at Insight Partners, commented:
“Delve’s approach has the potential to modernize not just compliance, but the entire way businesses operate.”
